Cryptococcal meningitidis Flashcards
Define Cryptococcal meningitidis
A fungal infection of the Meninges of the brain in immunocompromised patients.
What is the causative organism?
Cryptococcal neoformans
Encapsulated yeast that colonizes airways
What are the risk factors?
Immunocompromised e. g
°HIV (AIDS defining illness)
°Chemo patients
°CD4 count < 100cells/microL
°Transplant patients
°Corticosteroid usage
•Men (have prostate)
Which areas are mostly affected by cryptococcals
SPREAD VIA BLOODSTREAM
Brain- neoformans
Lungs- pulmonary cryptococcosis
Skin- cutaneous manifestations
Prostate
How is it ‘spread’?
°Inhaling spores (have no effect on immunocompetent)
What blood tests aid in diagnosis of CM
°Fungal culture and susceptibility test
°Cryptococcal serology
°Cryptococcal antigen testing
What cerebrospinal fluid tests are diagnostic for CM
°Fungal culture and susceptibility test (sensitivity>90%)
°Cryptococcal antigen testing
°India ink smear
°Elevated lymphocytes
°Hypoglycorrhachia (CSF glucose:serum glucose < 60%)
°Increased Intracranial pressure
°CSF clear or turbid
What differential tests are performed to verify CM
CSF antigen test with 90% sensitivity (negative result doesn't mean stop treatment)
CT or MRI to rule out brain tumor (do before lumbar puncture if presenting with focal neurologic deficits)
IN HIV PATIENTImmune Reconstruction Inflammatory Syndrome (IRIS) if HIV and severely immunosuppressed
Migraine headacheBacterial/meningococcal meningitis
Cytomegalovirus ventriculiencephalitis
Signs and symptoms of CM
Headache/fever/N/V
MalaiseAltered mental status with somnolence
PhotophobiaIncreased Intracranial pressure=papilledema (swollen optic disc)
Visual disturbancesStiffness/Nuchal rigidity
Confusion/Irritable/psychosis/psychomotor retardation
What are the goals of management in CM?
°Eradicate infection
°Reduce morbidity and mortality
°Prevent CM complications
°Prevent ADRs and toxicity related to meds
What are the 3 phases of CM treatment?
°Induction
°Consolidation
°Maintenance therapy
In the induction phase of CM treatment, what are the 1st line AND alternative therapies
1ST LINEAmphotericin B deoxycholate 0. 7mg/kg IV
ALTERNATIVE
Liposomal amphotericin B 3mg/kg IV
Both
With or without Flucytosine 25mg/kg PO q6h
Compare Liposomal amphotericin with amphotericin b deoxycholate
Liposomal=fewer infusion related side effects e. g blurred vision, convulsions
less nephrotoxicity
more expensive than deoxycholate
If the induction therapy with amphotericin b was successful (evidence led by clinical improvement and negative CSF culture), what is included in the consolidation phase?
°Fluconazole 400mg OD 8 weeks
°Then Fluconazole 200mg OD chronic maintenance therapy
OR
°Itraconazole 200mg PO BID then Fluconazole 200mg OD maintenance phase
Discontinue maintenance when CD4>100cells/microL and viral load is suppressed for at least 3 months and patient is on ART.
When do you suspect cytomegalovirus (CMV) in the patient?
If severely immunosuppressed